New allergy shot aims to tame dust mite misery
NCT ID NCT04184895
First seen Nov 01, 2025 · Last updated May 25, 2026 · Updated 32 times
Summary
This early-phase study tests a new shot (ASP2390) for adults with house dust mite allergies. The main goal is to see if the shot is safe and tolerable. Researchers will also measure changes in allergy-related antibodies. The study involves 28 participants and multiple doses.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALLERGIC TO HOUSE DUST MITES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Site DE49001
Berlin, Germany
-
Site DE49002
Hanover, Germany
Conditions
Explore the condition pages connected to this study.